Tyco Submarine

Syneos Health in Somerset offers scalable clinical and commercial solutions for navigating global development and delivery in today's complex market. Their services are designed to help clients successfully manage the challenges of the ever-evolving healthcare landscape. Generated from their website's infomation

The National Alliance for Musical Theatre (NAMT) is a prominent organization based in New York City that supports and promotes the development of new musical theatre works. With a membership of over 200 theatres, NAMT serves as a vital resource for writers, composers, and lyricists in the industry. Led by Executive Director Betsy King Militello, NAMT offers a range of programs and services, including conferences, grants, and networking opportunities, to foster the growth and success of new musicals. Under the guidance of Member Services Director Adam Grosswirth, NAMT provides exceptional customer service and support to its members. With a background in stage management and a deep understanding of the theatrical landscape, Grosswirth ensures that NAMT's members receive valuable resources, benefits, and access to a vibrant community of theatre professionals. Through their dedication to the art form, NAMT continues to play a crucial role in advancing the development and production of new musicals.Generated from the website

Roivant Sciences is a New York-based biotech company that is revolutionizing the discovery, development, and commercialization of new medicines. Through their innovative model of building agile and focused companies called Vants, Roivant aligns incentives to drive fast and high-quality execution, employing technology across all stages of the drug development process. With a strong focus on autoimmune diseases, Roivant's companies, including Immunovant, Dermavant, and Priovant, are dedicated to developing transformative therapies that have shown promising results in clinical trials. Roivant Sciences has gained recognition for its groundbreaking work, with 10 positive Phase 3 trials since 2019 and 6 FDA approvals. The company's commitment to innovation and its ability to leverage opportunities in the pharmaceutical industry have led to notable successes, such as the $3 billion sale of five of its companies to Sumitomo Pharma. With a broad and differentiated pipeline of investigational drugs, Roivant Sciences is at the forefront of advancing medicines that have the potential to make a significant impact on patient lives.Generated from the website